Dapiprazole is a drug having specific alpha1 adrenergic blocking properties. Following topical instillation on the eye, it crosses the corneal epithelium reaching high concentrations in the ocular tissue and producing a prompt miotic and hypotensive effect. The high concentration ratio between ciliary bodies and iris versus aqueous humor suggests a peculiar affinity for these structures containing adrenoceptors of the alpha type. The very low concentrations in the plasma, as compared to those after systemic administration, and in the fellow eye indicate that the systemic absorption is negligible. © 1986
Purpose. In our previous studies we reported that D1 dopaminergic agents increase IOP in presence of...
PURPOSE: To evaluate the effect of 3 types of topically applied miotic eyedrops on the pupil ...
[Background]: Pupillometry is used for the detection of autonomic dysfunction related to numerous di...
Dapiprazole produces miosis by blocking the alpha 1 receptors in the radial muscle of the iris; its ...
E' stato valutato il comportamento del polso oculare prima e dopo la somministrazione topica di dapi...
The treatment of posterior eye diseases, such as diabetic retinopathy and age-related macular degene...
Purpose: To evaluate the effect on pupil diameter of three different miotic eye-drops: aceclidine, b...
This chapter aims to provide the readers a systematic overview of the pharmacokinetics and pharmacod...
We have constructed a new ocular pharmacokinetic pharmacodynamic (PK/PD) model for anti-glaucomadrug...
Drug delivery to the posterior eye segment is an important challenge in ophthalmology, because many ...
Developing a population-based pharmacokinetic-pharmacody-namic (PKPD) model is a challenge in ophtha...
AIM: To compare the pharmacokinetic differences of the 2% diacerein eye drops between conjunctival s...
Twenty patients with POAG and early visual field changes, already under treatment with 0.5% timolol ...
Cumulative evidence indicates that propranolol (Inderal®), a 3-adrenergic antagonist blocking both P...
AIM: To determine the pharmacokinetics and distrubution of methylprednisolone sodium succinate(MPS)a...
Purpose. In our previous studies we reported that D1 dopaminergic agents increase IOP in presence of...
PURPOSE: To evaluate the effect of 3 types of topically applied miotic eyedrops on the pupil ...
[Background]: Pupillometry is used for the detection of autonomic dysfunction related to numerous di...
Dapiprazole produces miosis by blocking the alpha 1 receptors in the radial muscle of the iris; its ...
E' stato valutato il comportamento del polso oculare prima e dopo la somministrazione topica di dapi...
The treatment of posterior eye diseases, such as diabetic retinopathy and age-related macular degene...
Purpose: To evaluate the effect on pupil diameter of three different miotic eye-drops: aceclidine, b...
This chapter aims to provide the readers a systematic overview of the pharmacokinetics and pharmacod...
We have constructed a new ocular pharmacokinetic pharmacodynamic (PK/PD) model for anti-glaucomadrug...
Drug delivery to the posterior eye segment is an important challenge in ophthalmology, because many ...
Developing a population-based pharmacokinetic-pharmacody-namic (PKPD) model is a challenge in ophtha...
AIM: To compare the pharmacokinetic differences of the 2% diacerein eye drops between conjunctival s...
Twenty patients with POAG and early visual field changes, already under treatment with 0.5% timolol ...
Cumulative evidence indicates that propranolol (Inderal®), a 3-adrenergic antagonist blocking both P...
AIM: To determine the pharmacokinetics and distrubution of methylprednisolone sodium succinate(MPS)a...
Purpose. In our previous studies we reported that D1 dopaminergic agents increase IOP in presence of...
PURPOSE: To evaluate the effect of 3 types of topically applied miotic eyedrops on the pupil ...
[Background]: Pupillometry is used for the detection of autonomic dysfunction related to numerous di...